Photrexa cross-linking kit 6ML
Ended Awarded
- Contract number
- SPE2DB25FDRCE
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $37,056
Award facts
- Contract value 100% obligated
- $37,055.90 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $37,055.90 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Photrexa Cross-Linking Kit (6ml). The award, issued on September 24, 2025, with an ultimate completion date of October 16, 2025, utilizes firm fixed-price delivery order terms. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, a $500 million vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products and medical consumables supporting military health facilities nationwide. No set-aside designation was used for this specific delivery order.
Photrexa Cross-Linking Kit is a pharmaceutical product used in corneal cross-linking procedures, a specialized ophthalmological treatment. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, leveraging its woman-owned small business status to compete effectively in Defense Logistics Agency procurement markets. The company's portfolio demonstrates consistent success in securing contracts for diverse pharmaceutical products, ranging from prescription medications to specialty biologics and medical devices, supporting the Department of Defense's healthcare operations across military medical facilities worldwide.
Quick answers
Who was awarded contract SPE2DB25FDRCE?
SPE2DB25FDRCE was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 24, 2025.
How much is contract SPE2DB25FDRCE worth?
The government has obligated $37,056 on SPE2DB25FDRCE.
Is contract SPE2DB25FDRCE an order under another contract?
Yes. SPE2DB25FDRCE is a delivery order under SPE2DB24D9238, an indefinite delivery contract.
Was contract SPE2DB25FDRCE competed?
The extent of competition for SPE2DB25FDRCE was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award